Multiple Myeloma (MM) Clinical Trials in Hefei, Anhui
2 recruitingHefei, Anhui, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma (MM)
Shanghai Henlius Biotech258 enrolled81 locationsNCT07477587
Recruiting
Early Phase 1
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)AL Amyloidosis (AL)
Anhui Provincial Hospital36 enrolled1 locationNCT07085559